Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Material-Based Medical Engineering, Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan.
PLoS One. 2021 Jul 22;16(7):e0254160. doi: 10.1371/journal.pone.0254160. eCollection 2021.
Autologous vascular grafts are widely used in revascularization surgeries for small caliber targets. However, the availability of autologous conduits might be limited due to prior surgeries or the quality of vessels. Xenogeneic decellularized vascular grafts from animals can potentially be a substitute of autologous vascular grafts. Decellularization with high hydrostatic pressure (HHP) is reported to highly preserve extracellular matrix (ECM), creating feasible conditions for recellularization and vascular remodeling after implantation. In the present study, we conducted xenogeneic implantation of HHP-decellularized bovine vascular grafts from dorsalis pedis arteries to porcine carotid arteries and posteriorly evaluated graft patency, ECM preservation and recellularization. Avoiding damage of the luminal surface of the grafts from drying significantly during the surgical procedure increased the graft patency at 4 weeks after implantation (P = 0.0079). After the technical improvement, all grafts (N = 5) were patent with mild stenosis due to intimal hyperplasia at 4 weeks after implantation. Neither aneurysmal change nor massive thrombosis was observed, even without administration of anticoagulants nor anti-platelet agents. Elastica van Gieson and Sirius-red stainings revealed fair preservation of ECM proteins including elastin and collagen after implantation. The luminal surface of the grafts were thoroughly covered with von Willebrand factor-positive endothelium. Scanning electron microscopy of the luminal surface of implanted grafts exhibited a cobblestone-like endothelial cell layer which is similar to native vascular endothelium. Recellularization of the tunica media with alpha-smooth muscle actin-positive smooth muscle cells was partly observed. Thus, we confirmed that HHP-decellularized grafts are feasible for xenogeneic implantation accompanied by recellularization by recipient cells.
自体血管移植物广泛用于小口径靶标再血管化手术。然而,由于先前的手术或血管质量,自体移植物的可用性可能有限。来自动物的异种去细胞血管移植物可能是自体血管移植物的替代品。据报道,高压(HHP)去细胞化高度保留细胞外基质(ECM),为植入后再细胞化和血管重塑创造可行的条件。在本研究中,我们将高压去细胞化的牛背动脉异种植入猪颈动脉,并随后评估移植物通畅性、ECM 保留和再细胞化。在手术过程中避免移植物管腔表面因干燥而受损,显著增加了植入后 4 周的移植物通畅率(P = 0.0079)。在技术改进后,所有移植物(N = 5)在植入后 4 周时均保持通畅,仅因内膜增生而出现轻度狭窄。即使不使用抗凝剂或抗血小板药物,也没有观察到动脉瘤样改变或大量血栓形成。弹力纤维 Van Gieson 和 Sirius-red 染色显示 ECM 蛋白(包括弹性蛋白和胶原蛋白)在植入后得到了很好的保留。移植物的管腔表面被von Willebrand 因子阳性的内皮细胞彻底覆盖。植入移植物管腔表面的扫描电子显微镜显示出类似于天然血管内皮的鹅卵石样内皮细胞层。用α-平滑肌肌动蛋白阳性平滑肌细胞对中膜进行了部分再细胞化。因此,我们证实 HHP 去细胞化的移植物在受者细胞的伴随下进行异种植入和再细胞化是可行的。